International Journal of Drug Policy
Volume 16, Supplement 1 , Pages 45-57, December 2005

Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users

  • Richard H. Needle

      Affiliations

    • Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention, Global AIDS Program, 1600 Clifton Road, Mailstop E-04, Atlanta, GA 30333, USA
    • Corresponding Author InformationCorresponding author.
  • ,
  • Dave Burrows

      Affiliations

    • AIDS Projects Management Group, Level 2, 50 York St Sydney 2000, Australia
  • ,
  • Samuel R. Friedman

      Affiliations

    • National Development and Research Institutes, Inc., 71 West 23d Street, New York, NY 10010, USA
  • ,
  • Jimmy Dorabjee

      Affiliations

    • Centre for Harm Reduction, Macfarlane Burnet Institute for Medical Research and Public Health, P.O. Box 254, Yarra Bend Road, Fairfield, Vic. 3078, Australia
  • ,
  • Graziele Touzé

      Affiliations

    • Intercambios Asociacion Civil Av. Corrientes 2548 1a E (1046), Buenos Aires, Argentina
  • ,
  • Larissa Badrieva

      Affiliations

    • Project Renewal, 2a Vishnevskogo Street, Kazan 420097, Russia
  • ,
  • Jean-Paul C. Grund

      Affiliations

    • Addiction Research Centre (CVO), Keulsekade 223531 JX, Utrecht, The Netherlands
  • ,
  • Munirathinam Suresh Kumar

      Affiliations

    • Sahai Trust, 19 Vaidyaram Street, T Nagar, Chennai 600017, India
  • ,
  • Luciano Nigro

      Affiliations

    • Unit of Infection Diseases, University of Catania, Via Passo Gravina 185, 95125 Catania, Italy
  • ,
  • Greg Manning

      Affiliations

    • Community REACH, Pact, 1200 18th Street NW, Suite 350, Washington DC 20036, USA
  • ,
  • Carl Latkin

      Affiliations

    • Social and Behavioural Sciences, Johns Hopkins Bloomberg, School of Public Health, 737 Hamptom House, Baltimore, USA

Received 11 January 2005; accepted 6 February 2005.

Abstract 

This paper focuses on the evidence for the effectiveness of community-based outreach intervention as one component of a comprehensive HIV prevention model for preventing HIV infection in injecting drug user (IDU) populations. Three empirical questions guided the review of the evidence. This article includes primarily published literature on community-based outreach derived mostly from developing countries but also unpublished literature. Wherever possible, evidence from multi-country, multi-site studies or meta-analytical studies is included. More than 40 published studies reveal that injecting drug users (IDUs), who are reached by community-based outreach and provided with access to risk reduction services, report reducing HIV risk behaviours. The strength of the evidence was assessed using Hill's criteria, which permit a review of multiple studies with different designs. Using the criteria, it is possible to infer causation about the evidence of effectiveness of the intervention. The evidence for the effectiveness of a community-based outreach strategy is strong. Despite evidence from 20 years of evaluation studies of the effectiveness of community-based outreach, a huge gap exists in most countries between the number of IDUs who want or could benefit from outreach services and the number of IDUs who actually receive them. Findings from evaluation studies on the effectiveness of community-based outreach must be made accessible, disseminated globally and provided to policy- and decision-makers to persuade them to take action and implement scaled-up prevention programmes. This requires ongoing advocacy and constant strengthening of the evidence base. Plans are needed to link evidence-based findings with technical assistance as well as training to enhance the capacity of regions and countries to introduce, scale up and sustain HIV prevention outreach to IDUs as part of a comprehensive HIV prevention strategy.

Keywords: HIV/AIDS, Injection drug users, Evidence-based prevention, Community-based outreach, Risk reduction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(05)00096-4

doi:10.1016/j.drugpo.2005.02.009

International Journal of Drug Policy
Volume 16, Supplement 1 , Pages 45-57, December 2005